financetom
Business
financetom
/
Business
/
Ero Copper Up 2.1% After Hours as its Q4 Adjusted Profit Drops
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ero Copper Up 2.1% After Hours as its Q4 Adjusted Profit Drops
Mar 6, 2025 2:55 PM

05:33 PM EST, 03/06/2025 (MT Newswires) -- Ero Copper ( ERO ) rose 2.1% in after-hours New York trading after the company on Thursday said its fourth-quarter adjusted profit fell slightly.

Adjusted profit of $17.4 million, or $0.17 per share, was lower than the $20.7 million, or $0.21, in the prior year period.

Quarterly revenue rose to $122.5 million, from $116.4 million.

The Brazil miner said quarterly copper production totaled 8,566 tonnes, bringing full-year copper production to 35,444 tonnes in concentrate.

The company reaffirmed its 2025 production of between 75,000 to 85,000 tonnes of copper. Ero is focused on achieving commercial production at the Tucuma Operation in the first half of this year.

Ero Copper ( ERO ) shares were last seen up US$0.26 to $12.60 after hours. They closed down $0.03, to $17.71, on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Quoin Pharmaceuticals Shares Jump After Announcing $104.5 Million Private Placement
Quoin Pharmaceuticals Shares Jump After Announcing $104.5 Million Private Placement
Oct 10, 2025
10:12 AM EDT, 10/10/2025 (MT Newswires) -- Quoin Pharmaceuticals ( QNRX ) shares jumped nearly 170% in recent Friday trading after the company said it has reached an agreement with healthcare-focused institutional investors to sell securities worth up to $104.5 million in a private placement. The drugmaker said it will sell about 2 million American depositary shares or pre-funded warrants...
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly
Oct 10, 2025
By Bhanvi Satija and Maggie Fick LONDON, Oct 10 (Reuters) - Wall Street is looking to U.S. drugmaker Eli Lilly ( LLY ) and Anglo-Swedish rival AstraZeneca ( AZN ) as the potential next in line after Pfizer ( PFE ) struck a deal with Donald Trump's administration to lower drug prices last week. Reuters spoke to seven healthcare analysts...
Bitfarms Converts Debt Facility Into $300 Million Funding for Pennsylvania Data Center Campus
Bitfarms Converts Debt Facility Into $300 Million Funding for Pennsylvania Data Center Campus
Oct 10, 2025
10:10 AM EDT, 10/10/2025 (MT Newswires) -- Bitfarms ( BITF ) said Friday that it has converted its existing private debt facility for up to $300 million from Macquarie Group's Commodities and Global Markets business into a project-specific financing facility for its data center campus in Panther Creek, Pennsylvania. The company said it will draw an additional $50 million from...
BP Scores Major Win Against Venture Global In LNG Dispute
BP Scores Major Win Against Venture Global In LNG Dispute
Oct 10, 2025
Venture Global, Inc. ( VG ) shares are tumbling premarket on Friday after a wholly-owned subsidiary of BP p.l.c ( BP ). won an arbitration against the company over its failure to supply liquefied natural gas. BP Wins Arbitration Against Venture Global This week, the International Chamber of Commerce (ICC) issued a partial final award in the arbitration with BP...
Copyright 2023-2026 - www.financetom.com All Rights Reserved